ArticleBreast cancer research and treatment2021

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

N I Bouwer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.